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Original Article 
Inflammatory Mediators, Infection, Sepsis, and Multiple 
Organ Failure After Severe Trauma 
Christian Waydhas, MD; Dieter Nast-Kolb, MD; Marianne Jochum, PhD; Arnold Trupka; Susann Lenk; 
Hans Fritz, PhD; Karl-Heimo Duswald, MD; Leonhard Schweiberer, MD 
• The relation of (multiple) organ failure (OF) to the release 
of inflammatory mediators and the incidence of infection 
and sepsis was studied prospectively in 100 patients with 
multiple trauma (injury severity score = 37). Sixteen pa-
tients died of OF, 47 patients survived OF, and 37 patients 
had no OF. Fifteen (24%) of the patients with OF showed 
no signs of infection. In patients with early onset of OF 
(n = 45), infection followed with a lag of 2 or more days. In 
16 (44%) of these patients, infection led to a deterioration 
in organ function. With late onset of OF (n = 18), infection 
preceded OF in nine patients. Polymorphonuclear leu-
kocyte-elastase, neopterin, C-reactive protein, lactate, an-
tithrombin III, and phospholipase A discriminated signifi-
cantly among the three outcome groups. Of all factors, only 
polymorphonuclear leukocyte-elastase showed a differ-
ence between patients with and without infection or sepsis, 
respectively. These data indicate that infection might not 
play a crucial role in the pathogenesis of posttraumatic OF 
in a substantial portion of patients with trauma. Early OF, 
especially, seems to be mainly influenced by the direct se-
quelae of tissue damage and shock (eg, the release of 
inflammatory mediators). Since infection and sepsis did not 
lead to an augmented release of mediators in patients with 
trauma, the role of both entities remains unclear. 
(Arch Surg. 1992;127:460-467) 
The major cause of late death after severe blunt trauma is (multiple) organ failure (OF). It is usually attrib-
uted to infectious complications that develop in the post-
traumatic course leading to dysfunction of the respiratory 
and other organ systems.1"4 Sepsis is the commonly used 
denominator for the clinical presentation of the syn-
drome. Thus, sepsis is generally regarded as the main 
cause of OF and late death after severe trauma. As a rule, 
a proven bacterial focus is mandatory in most definitions 
of sepsis. However, in the initial descriptions of multiple 
Accepted for publication October 5,1991. 
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O F , 5 6 it was already pointed out that despite the unifor-
mity of the syndrome, a variety of causes other than in-
fection may lead to organ dysfunction. For example, a 
clinical picture resembling sepsis can be found in acute 
pancreatitis in humans. Experimental studies were able to 
induce a sepsislike syndrome with nonbacterial, nonen-
dotoxic inflammatory stimuli.7'8 Thus, several authors 
suggested that multiple OF after trauma may be the direct 
consequence of mediators released during tissue damage 
and circulatory shock and not of infectious sequelae.9 1 0 To 
describe this syndrome, terms such as "whole body 
inflammation"11 or "nonbacteremic clinical sepsis"1 2 were 
introduced. To further elucidate the role of inflammatory 
mediators and infection in the development of multiple 
OF, we have performed a prospective study in severely 
injured patients. 
PATIENTS AND METHODS 
During the study period (1986 to 1990), traumatized patients 
arriving at our emergency department were examined immedi-
ately by a member of the study team and included in the 
prospective study if all of the following criteria were met: (1) less 
than 6 hours between accident and admission to the emergency 
department; (2) between 16 and 70 years of age; and (3) severe 
injuries of at least two body regions (head/brain, thorax, abdo-
men, skeletal system) or three major fractures. Severe injuries 
included the following: (1) head— unconsciousness for more 
than 60 minutes or with dilated pupil(s), cerebrospinal fluid rhi-
norrhea or otorrhea, unstable facial bone fracture; (2) thorax— 
more than three fractured ribs, sternum fracture, pneumothorax/ 
hemothorax, lung contusion, aortic rupture, cardiac tamponade, 
rupture of the diaphragm; (3) abdomen— hollow or parenchy-
mal organ laceration, renal contusion or laceration; (4) skeletal 
system— vertebral lesion (fracture of vertebral body or arch, lig-
amentous injury with dislocation, spinal cord injury), pelvic 
fractures, fractures of the femur, tibia, and/or humerus, ampu-
tations proximal to the toes or digits. 
Collection of blood samples for routine and biochemical lab-
oratory testing as well as recording of clinical data, including di-
agnostic and therapeutic interventions, drug and infusion ther-
apy, Glasgow Coma Scale, and cardiopulmonary monitoring 
data, were started within 30 minutes after arrival of the patient 
in the emergency department and continued on a 6-hour basis. 
After 48 hours, the interval was extended to 24 hours for a pe-
riod of 14 days. After 2 weeks, the clinical course was recorded 
until either transfer to a general ward or death. 
Biochemical measurements using commercially available test 
kits included polymorphonuclear leukocyte (PMN)-elastase (E. 
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Merck, Darmstadt, Germany), C-reactive protein (Behring-
werke, Marburg, Germany), antithrombin ΠΙ (Kabi, Stockholm, 
Sweden), neopterin (Henning, Berlin, Germany), and phospho-
lipase Α (Boenringer, Mannheim, Germany). Testing for bacte­
ria from the urinary tract and the bronchial system was routinely 
done twice a week or when clinically indicated. Blood cultures 
were taken when the body temperature rose above 38.5°C. 
Swabs for bacterial cultures were taken from all catheter tips and 
from wounds when indicated. The following definitions were 
used. Sepsis was assumed when two signs of the following signs 
1 to 3 in addition to sign 4 occurred: (1) temperature of 38.5°C or 
greater; (2) white blood cell count (WBC) greater than or equal 
to 15 x 109/L or less than or equal to 5 x 109/L ; (3) thrombocytes 
less than or equal to 100 x 109/L or a fall of greater than or equal 
to 30% in 24 hours; and (4) culture-proved bacterial focus. 
Pneumonia was supposed when one sign of the following 
signs 1 to 2 plus one sign of signs 3 to 4 occurred: (1) tempera­
ture of 38.5°C or greater;, (2) WBC of 12xl07L or greater; (3) 
positive bacterial culture; (4) abnormal roentgenographic signs 
typical of pneumonia. Urinary tract infections were considered 
to cause the following signs: (1) positive culture with more than 
104 bacteria per milliliter; (2) temperature of 38.5°C or greater; (3) 
WBC of 12 x 109/L or greater. Catheter infection was considered 
to cause the following signs: (1) temperature of 38.5°C or greater; 
(2) WBC of 12 x 109/L or greater; (3) positive culture from cathe­
ter tip. Respiratory failure was indicated by the following signs: 
need of mechanical ventilation and Po2/fraction of inspired ox­
ygen of 280 mm Hg or less or positive end-expiratory pressure 
of 8 mm Hg or greater for at least 24 hours. Renal failure was in­
dicated by a creatinine concentration of 177 μηιοΙ/L or greater for 
at least 48 hours. Liver failure was indicated by a bilirubin level 
of 51 μηιοΙ/L or greater for at least 48 hours. Disseminated intra­
vascular coagulation was indicated by the following signs: (1) 
thrombocyte level of 100 x 109/L or less or a fall of 30% or more 
in 24 hours; (2) partial thromboplastin time of 50 seconds or more 
for 24 hours; (3) reptilase time of 22 seconds or more for 24 hours 
(similar to the test for thrombin time, but with use of the 
heparin-independent thrombinlike enzyme reptilase instead of 
thrombin.13 Gastrointestinal tract failure was indicated by endo-
scopically proved ulceration with bleeding or acalculous chole­
cystitis. 
Multiple OF was assumed if two or more organ systems failed 
at the same time. Statistical testing was done with the nonpara-
metric Wilcoxon Test for two samples and the χ2 test with Yates' 
correction. Differences were considered significant with Ρ values 
less than .05 and highly significant with Ρ values less than .01. 
The study was carried out in accordance with the Ethical Com­
mittee of the Ludwig Maximilians-University, Munich, Ger­
many. 
RESULTS 
One hundred seventeen patients entered the study. 
Seventeen patients died during the first 24 hours; the re­
maining 100 primary survivors formed the basis of the 
following results. The mean injury severity score was 37 
points (range, 13 to 66 points). There were 74 male and 26 
female patients with a mean age of 38 years. Sixteen pa­
tients (16%) died between days 3 and 28 (median surviv­
ing time, 16 days). 
The overall incidence of OF, infection, and bacterial 
sepsis is listed in Table 1. The bacterial foci of sepsis were 
pneumonia (n = 18), wound infection (n = 5), urinary tract 
infection (n = 2), catheter infection (n = 1), and peritonitis 
(n = 1). In Table 2, patients are divided into nonsurvivors 
(group 1), survivors with OF (group 2), and survivors 
without OF (group 3). The incidence of pneumonia and 
bacterial sepsis did not differ significantly between 
groups 1 and 2 (P>.1). The rate of pneumonia, infection, 
and bacterial sepsis was significantly higher in groups 1 
Arch Surg-Vol 127, April 1992 
Table 1.—Incidence of Organ Failure, Infection, 
and Sepsis in 100 Patients With Trauma* 
Factor % 
Organ failure 
Isolated 
Multiple 
63 
31 
32 
Pneumonia 46 
Urinary tract infection 8 
Wound infection 15 
Catheter infection 1 
Peritonitis 1 
No infection 43 
Sepsis 27 
The occurrence of more than one infectious focus in a patient 
is possible. 
Table 2.—Incidence of Multiple Organ Failure (OF), 
Infection, and Bacterial Sepsis in Three Outcome 
Groups of Patients With Trauma* 
Group 1 Group 2 Group 3 
No. of patients 16 47 37 
Mean ISS 43 39 32 
Multiple OF, No. (%) 15 (94) 16 (34) 
Infection, No. (%) 13 (81) 35 (74) 9(24) 
No infection, No. (%) 3 (19) 12 (26) 28 (76) 
Sepsis, No. (%) 8 (50) 17 (36) 2 (5) 
*Group 1 comprises nonsurvivors; group 2, survivors with OF; 
and group 3, survivors without OF. Percent sign indicates percent­
ages within each group. ISS indicates injury severity score. 
and 2 compared with group 3 (P<.0001). However, nearly 
a quarter of the patients in groups 1 and 2 did not show 
signs of bacterial infection at any time. Ninety-three per­
cent of all cases of bacterial sepsis were observed in 
patients with OF, whereas only 7% of all patients with 
bacterial sepsis had no organ insufficiency. Although a 
high coincidence of bacterial sepsis and OF could be ver­
ified, several patients with infection and even sepsis had 
no development of OF. 
In Fig 1, the starting points of OF, infections, and sep­
sis in relation to trauma are displayed. In most cases 
(n = 45), OF became obvious during the first 2 days after 
trauma (usually respiratory failure). A second peak 
emerged between days 6 and 8, predominantly due to 
liver failure. This second rise either represents the onset 
of late OF or a deterioration in the patient's condition with 
the development of multiple OF. Infections came up at 
day 3 and remained fairly constant for about a week. Bac­
terial sepsis occurred with a slight delay. The leading in­
fection was pneumonia. There was a high correlation of 
pneumonia with the duration of mechanical ventilation. 
While patients who were being mechanically ventilated 
for less than 5 days had an 8% rate of intrapulmonary in­
fection, the incidence of pneumonia rose to 71% as the 
duration of ventilation increased. Patients from groups 1, 
2, and 3 were ventilated 15.8, 12.5, and 4.7 days, respec­
tively. 
According to the onset of OF, two groups were formed 
(early and late onset of OF) and the starting point of in­
fection and sepsis relative to OF was defined in each sin­
gle patient. The condensed data are shown in Table 3. Of 
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Fig 1.—Frequency distribution of onset of organ failures, infection, 
and sepsis in WO patients with trauma during 14 posttraumatic days. 
The number on the y-ax/s signifies the number of patients in whom 
organ failure (squares), infection (plus signs), and sepsis (asterisks) 
starts on the specific day. 
Table 3.—Onset of Infection in Relation to Onset of 
Organ Failure (OF) in Patients With Trauma With OF 
Starting Within the First 3 Days After Trauma (n = 45) 
Infection Sepsis 
Onset of infection/sepsis 
2*2 d before OF 
1 d before to 1 d after OF 
2*2 d after OF 
No infection/sepsis 
1 
35 
1 
18 
26 
45 patients with early onset of OF (within the first 3 days 
after trauma), 36 showed signs of infection. Of those, 
bacterial complications and sepsis could be recognized 
only 2 or more days after OF in 35 (97%) and 34 (95%) pa­
tients, respectively. In 16 patients (44%), infection was 
followed by a deterioration of organ function. Twelve of 
18 patients with late OF (after the third posttraumatic day) 
suffered from bacterial complications (Table 4). Infection 
preceded or coincided with the onset of OF in nine 
patients (75%), whereas three patients (25%) showed 
signs of infection only several days after late OF. 
The release of mediators and indicators of inflammatory 
reactions in the three outcome groups is displayed in Fig 
2. Polymorphonuclear leukocyte-elastase showed a 
highly significant difference (P<.01) between groups 1 or 
2 vs 3 throughout the whole observation period and be­
tween groups 1 vs 2 (P<.05) after the third day. Neopterin 
was significantly (P<0.05) higher in group 1 (nonsurvi­
vors) compared with survivors (group 2 or 3) from the 
second day onward and between groups 2 vs 3 after the 
fourth posttraumatic day. The production of C-reactive 
protein was significantly different (P<.01) between all 
outcome groups starting on the third day after trauma. A 
significantly higher accumulation of lactate (P<.01) could 
be observed in nonsurvivors (group 1) compared with 
survivors with OF (group 2) throughout the 14 days of 
observation. Moreover, lactate levels of group 2 differed 
significantly (P<.01) from those of group 3 during the first 
8 days. Antithrombin III showed a significantly lower in­
hibitory activity (P<.01) in groups 1 or 2 vs 3 all the time 
and between groups 1 and 2 (nonsurvivors vs survivors 
with OF) (P<.05) after the first week. In contrast, a 
significant difference in plasma levels of phospholipase A 
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Table 4.—Onset of Infection in Relation to Onset of 
Organ Failure (OF) in Patients With Trauma With OF 
Starting After the Third Posttraumatic Day (n = 18) 
Infection Sepsis 
Onset of infection/sepsis 
2*2 d before OF 
1 d before to 1 d after OF 
^2 d after OF 
No infection/sepsis 
1 
4 
1 
12 
among the three groups became obvious only after more 
than a week following trauma. 
For the same factors, a comparison was accomplished 
between patients suffering from infection/sepsis and 
those who did not sustain these entities. To exclude the 
above-described influence of outcome, the comparison 
was performed separately within each outcome group. In 
the following figures, the results of the largest group 
(survivors with OF, group 2) are shown, which are sim­
ilar to the results of the other two groups. 
Figure 3 represents the graphs for patients with and 
without infection. No significant differences were ob­
served for any of the factors, except for PMN-elastase, 
which differentiated between infected and noninfected 
patients. 
The plasma levels of mediators of patients with and 
without sepsis are shown in Fig 4. The elastase values 
were significantly higher in patients in whom these signs 
of bacterial sepsis developed than in those in whom signs 
did not develop. This difference became obvious from the 
second posttraumatic day onward with Ρ values usually 
varying between .01 and .05. None of the other factors 
(neopterin, C-reactive protein, lactate, antithrombin III, 
phospholipase A) showed a clear discrimination between 
patients with and without bacterial sepsis at any time. 
COMMENT 
In 1980, Fry et al1 published results of 553 patients who 
underwent emergency operations, of whom 38 had de­
velopment of multiple OF. Thirty-four of these patients 
showed signs of infection and the authors concluded that 
infection and its systemic manifestations were the most 
crucial factor in the evolution of OF in patients after sur­
gery. Infection was found in 46 of 47 patients with lethal 
adult respiratory distress syndrome in a necropsy study.14 
Thus, a major role of infection in the pathogenesis of OF 
was established for patients following surgery and for 
patients with internal disease. 
In the original communications of multiple O F , 5 / 6 how­
ever, it has been shown that in addition to infection, other 
inflammatory processes or hypotension may lead to mul­
tiple OF. In our prospective series of multiply injured pa­
tients, about a quarter of all individuals with isolated or 
multiple OF did not show any signs of bacterial infection 
at all. Similar observations were made by several other 
authors: Goris et al7 failed to prove infection in 24 (43.6%) 
of 55 severely injured patients with lethal multiple OF. 
Border10 found negative blood cultures in two thirds and 
no septic focus in one third of his patients with multiple 
OF following trauma. In another study 49 (56%) of 88 pa­
tients with adult respiratory distress syndrome did not 
show signs of infection.15 Moreover, in a further investi­
gation, no sepsis was observed in six (23%) of 26 patients 
with multiple O F . 1 6 However, in this study, the cases of 
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13 patients with sepsis but without multiple OF were re­
ported. This result corresponds to that obtained with our 
nine patients suffering from sepsis/infection without or­
gan dysfunction (Table 2). Therefore, it can be concluded 
that sepsis does not necessarily lead to OF. 
All these communications provide reasonable evidence 
that multiple OF following trauma is present in 25% to 
50% of patients without signs of bacterial infection. Thus, 
OF occurs without the pathogenetic pacemaker of infec­
tion in a substantial portion of patients with trauma. To 
further evaluate the role of infection in patients with OF, 
we analyzed the temporal relation between onset of OF 
and diagnosis of infection. 
In those patients who sustained early OF within 3 days 
after trauma, a substantial part showed no signs of infec­
tion (20%) or sepsis (58%) in our study. Those who suf­
fered from infectious entities usually did so only 2 or more 
days after the manifestation of OF. Similar observations 
were made by other authors17 who could not prove sepsis 
in 15 severely injured patients with early multiple OF. In 
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patients with early OF, the severity of the initial trauma 
and its biochemical sequelae seemed responsible for the 
development of OF. Infection and sepsis followed, if at 
all, with a lag of at least 2 days. Infections did not influ­
ence the posttraumatic course in 56% of the patients in our 
series. On the other hand, in 44% a further deterioration 
in the patient's organ dysfunctions became obvious when 
infections supervened. 
Eighteen patients had development of late OF after the 
third posttraumatic day. In this group of patients, infec­
tion could not be observed in 33%. If present, however, 
signs of infection were recorded at the same time or even 
before OF started in 75% of patients. Therefore, a caus­
ative role of bacterial infection in the development of OF 
can be assumed in this subset of patients. This observa­
tion corresponds to those of other authors17 who have 
found sepsis in all patients with delayed onset of OF. 
Monitoring of mediators and indicators of the inflamma­
tory response to a variety of stimuli allows a more precise 
description of the body's reaction than can be achieved 
with clinical data alone. The release of these factors may 
be triggered by direct tissue trauma, tissue hypoxia in cir­
culatory shock, infection, and sepsis or others. Some of 
them (eg, C-reactive protein, neopterin, lactate) are indi-
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cators of the inflammatory response and do not seem to 
have any causative role of their own in the development 
of OF. Others, such as PMN-elastase, antithrombin III, or 
phospholipase A may lead to proteolytic tissue damage,18 
play a role in the formation of thromboembolism,19 or en­
hance the arachidonic acid pathway.20 In experimental 
models and clinical studies, 7 8 a pathogenetic significance 
could be attributed to these mediators; their actual role in 
the development of posttraumatic OF, however, remains 
incompletely defined. Many other biochemical pathways 
not determined in this study are involved in the process 
of OF. Yet, those factors presented herein are known to 
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correlate highly with traumatic or septic events. For 
example, the neutral proteinase PMN-elastase is released 
from the primary inflammatory cells (PMN granulocytes) 
by major surgery 1 8 / 2 1 and trauma1 1'2 2'2 4 and correlates well 
with the severity of trauma.1 1'2 2 Furthermore, elastase al­
lowed the differentiation between surgical patients with­
out complications, septic survivors, and septic nonsurvi-
vors in one series18 and the septic nonsurvivors and 
nonseptic patients in another.25 Neopterin, an indicator of 
macrophage activity, showed significant differences be­
tween survivors and nonsurvivors26 and septic and non-
septic patients in an intensive care unit. 2 5 C-reactive pro-
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tein is an acute-phase reactant that may serve as an 
indicator of the activation of cytokine pathways. It is not 
only raised in septic shock 1 8 2 7but also shows an elevation 
in patients who have sustained trauma with significant 
differences between mild injuries, severe injuries without 
complications, and those with sepsis. 2 8 Antithrombin III, 
the main inhibitor of the coagulation system, has been 
shown to differ significantly between survivors and non­
survivors suffering from septic shock, 2 7 1 9 septic and non-
septic patients,19 and patients with trauma with and 
without hypotension.29 Phospholipase A, an inducer of 
the arachidonic acid metabolism, was shown to correlate 
highly with hypotension in septic shock.20 
In our series of 100 severely injured patients, all of these 
mediators and indicators of the inflammatory response 
showed a high correlation with the patients' outcome. The 
differentiation among nonsurvivors (all with OF), survivors 
with OF, and survivors without OF was possible already 
within the first hours after the accident using the plasma lev­
els of elastase, lactate, and antithrombin ΙΠ or after a few days 
with the help of neopterin, C-reactive protein, and phospho­
lipase A values. These differences were observed before in­
fections or bacterial sepsis could be anticipated and remained 
throughout a period of 2 weeks. We therefore conclude that 
it is mainly the severity of the initial trauma and its biochem­
ical sequelae that trigger the release of inflammatory medi­
ators and indicators not only in the immediate posttraumatic 
period but also in the later course where it can lead to a pro­
longed disturbance of the homeostasis. 
Since blunt trauma as well as bacterial complications 
and sepsis initiate the release of mediators and indicators 
(see above), we compared the reaction of these mediators 
in severely traumatized patients with and without infec­
tion and sepsis. Increased levels of inflammatory reac-
tants should be expected in individuals with infectious 
complications. Surprisingly, only the elastase values were 
significantly higher in patients with sepsis and infections 
as compared with the other patients, whereas no other 
mediator seemed to be affected by sepsis or infection. Al­
though it cannot be ruled out completely that sepsis starts 
in different patients at different times, thus smoothing 
differences, Fig 1 shows a peak of septic events between 
days 5 and 9. One might assume that due to the perma­
nent influx of intact bone marrow-derived cells, the acti­
vation of PMN granulocytes precedes this period (Fig 4), 
thus indicating a contribution of PMN cell constituents to 
the development of sepsis. In contrast, the body's ability 
to produce or consume (eg, antithrombin III) the other 
mediators in an augmented amount seems to be either 
exhausted after the trauma-induced activation or does not 
even take place. Therefore, these mediators do not seem 
to play a crucial role for onset or duration of the septic 
event in the later course. The observation of a high rate 
of infections in patients with trauma, despite a lack of 
mediator release, might lead to the speculation that one 
main stem of our diagnosis of infection, namely the bac­
terial focus, may be just a sign of bacterial overgrowth due 
to the failing immune system and not represent a genu­
ine infection leading to OF in several patients. 
In conclusion, isolated and multiple OF in severely in­
jured patients seems to have a variety of causes and can­
not be attributed exclusively to infection. (1) In about a 
quarter of patients with OF, infection does not seem to 
play a significant role at any time. (2) Of those patients 
with infection, three quarters show an early onset of OF 
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long before infection starts. In only half of them, infection 
or sepsis leads to a consecutive deterioration of organ 
functions. In patients with late onset of OF, infection and 
sepsis precede the disturbance of organ function and 
seem to have pathogenetic significance. (3) The release or 
activation of mediators and indicators of the inflammatory 
response are mainly dependent on the severity of injuries. 
Only PMN-elastase showed a correlation with sepsis and 
infection, whereas the other factors were not influenced 
by bacterial complications, indicating that PMN cell con­
stituents may contribute to the occurrence of sepsis. 
The cause of OF is not always clear in the individual 
patient with trauma. The classic bacterial infection is not 
the sole contributor to the multiple OF syndrome. Since 
the term sepsis is closely related to a bacterial infection, we 
suggest that this diagnosis no longer be used in patients 
who have sustained trauma. 
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